# Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases

> **NCT02220491** · NA · COMPLETED · sponsor: **British Columbia Cancer Agency** · enrollment: 20 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** Single-fraction radiotherapy
- **RADIATION:** Whole-brain radiotherapy

## Key facts

- **NCT ID:** NCT02220491
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-01
- **Primary completion:** 2020-05-18
- **Final completion:** 2020-05-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220491, "Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02220491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*